Comparing efficacy of Rivaroxaban versus Warfarin on carotid plaque

Phase 2

• Conditions: Stroke.; Cerebrovascular disease, unspecified; I67.9

• Registration Number: IRCT20190729044372N1
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Non -valve artrial fibrillation with stroke or TIA or IF<30%
Not taking Asprin
Lack of kidney and liver diseases and other specific disease

Exclusion Criteria

Having a heart valve disorder
Taking Asprin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Carotid plaque size. Timepoint: Baseline and 6 months later. Method of measurement: Bilateral carotid artery color Doppler ultrasound.;Internal and common carotid stenosis grade. Timepoint: Baseline and 6 months later. Method of measurement: Bilateral carotid artery color Doppler ultrasound.;Create new carotid artery plaque. Timepoint: Baseline and 6 months later. Method of measurement: Bilateral carotid artery color Doppler ultrasound.

Secondary Outcome Measures

Name	Time	Method
Brain stroke. Timepoint: At baseline and 6 Months later. Method of measurement: Bilateral carotid artery color Doppler ultrasound.;Probability of recurrence of stroke. Timepoint: At baseline and 6 Months later. Method of measurement: Bilateral carotid artery color Doppler ultrasound.